Biotech Update: Provectus (PVCT) and Nordion (NDZ)   2 comments

I made two moves with my biotech stocks today.

First, I sold half of my Provectus (PVCT) at $0.94, for a small profit. I wanted to cut down on the size of my position. The semi-final line on it:

PVCT: +0.08 today, +0.01 overall to $0.94 (+9.30% today, +1.08% overall)–bought at $0.93

Second, I doubled Nordion (NDZ) at $8.18, lowering my dollar cost average to $8.42. It is still a small position.

Advertisements

Posted December 2, 2013 by edmcgon in Portfolio Moves

2 responses to “Biotech Update: Provectus (PVCT) and Nordion (NDZ)

Subscribe to comments with RSS.

  1. Ed any reason for the spike in pvct?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: